DOI: 10.36347/sasjs

Pages: 224-228

Significant variability exists throughout the world in the extent of lymphedenectomy which is performed for Gastric adenocarcinoma. Lymph node metastasis is the most important prognostic factor in gastric cancer and for this reason gastrectomy with lymphadenectomy is the only curative treatment option for it. This article reviews the evidence on the extent of lymphadenectomy that should be performed for gastric adenocarcinoma. For the present retrospective study we considered 46 patients from which 40 are resectable and undergone surgical resection and D2 lymphadenectomy for gastric adenocarcinoma from January 2009 – December 2011. Total gastrectomies were performed in 18 patients and rest 22 patients were undergone radiacl D2 gastrectomy. We tried to remove minimum of 16 lymph nodes. Most of the cases are of stage II and III. After 3 years of follow-up of our patients mortality rate is 2 (5%) and recurrence rate is 5 (12.5%)